Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol.
Al-Laith, Mariam
Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol. [electronic resource] - Trials Jul 2019 - 429 p. digital
Publication Type: Clinical Trial Protocol; Journal Article
1745-6215
10.1186/s13063-019-3403-7 doi
Abatacept--administration & dosage
Antirheumatic Agents--administration & dosage
Arthritis, Rheumatoid--diagnosis
Autoantibodies--blood
Biomarkers--blood
Double-Blind Method
Drug Administration Schedule
Feasibility Studies
Female
Humans
Male
Multicenter Studies as Topic
Netherlands
Pregnancy
Randomized Controlled Trials as Topic
Time Factors
Treatment Outcome
United Kingdom
Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol. [electronic resource] - Trials Jul 2019 - 429 p. digital
Publication Type: Clinical Trial Protocol; Journal Article
1745-6215
10.1186/s13063-019-3403-7 doi
Abatacept--administration & dosage
Antirheumatic Agents--administration & dosage
Arthritis, Rheumatoid--diagnosis
Autoantibodies--blood
Biomarkers--blood
Double-Blind Method
Drug Administration Schedule
Feasibility Studies
Female
Humans
Male
Multicenter Studies as Topic
Netherlands
Pregnancy
Randomized Controlled Trials as Topic
Time Factors
Treatment Outcome
United Kingdom